Oxalate Worsens Gut Inflammation in IBD

Recent research published in Cellular and Molecular Gastroenterology and Hepatology reveals that dietary oxalate, a natural compound found in healthy foods like spinach, almonds, and sweet potatoes, may actively worsen intestinal inflammation in individuals suffering from inflammatory bowel disease (IBD) such as Crohn's disease and ulcerative colitis. Led by researchers at the University of North Carolina at Chapel Hill School of Medicine, including postdoctoral scholar Anna Salvador and professor Shehzad Z. Sheikh, the study discovered that patients with IBD exhibit a fundamental defect in intestinal handling rather than simply consuming more oxalate. Specifically, intestinal transporter proteins like SLC26A2, SLC26A3, and SLC26A6 are consistently reduced in these patients, leading to oxalate accumulation and heightened immune responses. Animal experiments demonstrated that mice on an oxalate-supplemented diet combined with a colitis-inducing agent experienced significantly lower survival rates and accelerated inflammation. Furthermore, laboratory analyses showed that oxalate directly intensifies inflammatory responses in macrophages and dendritic cells, while low expression of the SLC26A6 transporter correlates strongly with stricturing Crohn's disease. These findings provide a novel molecular framework for understanding diet-disease interactions in IBD, suggesting that future therapies could focus on modifying dietary oxalate content, targeting transporter mechanisms, or restoring beneficial gut bacteria like Oxalobacter formigenes to safely manage gut inflammation without eliminating nutritious plant foods.